Patients with tungiasis often present with itching, irritation, and pain at the site of infestation, usually on the feet. The affected area may show a small black dot, which is the flea's rear end, surrounded by a white halo of skin. As the flea enlarges, the lesion can become inflamed and ulcerated, potentially leading to secondary infections. In severe cases, multiple lesions can cause difficulty walking and other complications.

Diagnosis of tungiasis is primarily clinical, based on the characteristic appearance of the lesions. A thorough examination of the affected area is essential. In some cases, dermoscopy, a technique that uses a magnifying lens and light, can help visualize the flea. Laboratory tests are generally not required unless there is suspicion of a secondary bacterial infection, in which case a culture may be performed.

The primary treatment for tungiasis involves the careful extraction of the embedded flea. This should be done with sterile instruments to prevent infection. After removal, the area should be cleaned and dressed. Topical antibiotics may be applied to prevent secondary infections. In cases of severe infestation, oral antibiotics or antiparasitic medications may be necessary. Pain relief and anti-inflammatory medications can help manage symptoms.

With appropriate treatment, the prognosis for tungiasis is generally good. Lesions typically heal within a few weeks after the flea is removed. However, if left untreated, tungiasis can lead to complications such as secondary infections, tetanus, or even gangrene in severe cases. Recurrence is possible, especially in endemic areas, highlighting the importance of preventive measures.

Tungiasis is caused by the female Tunga penetrans flea. After mating, the female flea seeks a warm-blooded host, often humans, to complete its life cycle. It burrows into the skin, where it feeds on blood and lays eggs. The flea's presence in the skin causes the characteristic symptoms of tungiasis.

Tungiasis is endemic in tropical and subtropical regions, particularly in sub-Saharan Africa, the Caribbean, and South America. It predominantly affects impoverished communities with poor housing conditions, inadequate sanitation, and limited access to healthcare. Children and the elderly are more susceptible due to their increased exposure and reduced mobility.

Once the female Tunga penetrans flea penetrates the skin, it begins to feed on the host's blood. The flea's body enlarges as it matures and produces eggs, causing the surrounding tissue to become inflamed and irritated. The flea's presence triggers an immune response, leading to the characteristic symptoms of itching, pain, and swelling.

Preventing tungiasis involves reducing exposure to the fleas. This can be achieved by wearing closed footwear, especially in endemic areas, and maintaining good personal hygiene. Improving living conditions, such as using insecticides and ensuring proper sanitation, can also help reduce the risk. Community education on the importance of these measures is crucial in endemic regions.

Tunga penetrans, or the chigoe flea, causes tungiasis, a condition characterized by painful skin lesions. It is prevalent in tropical regions and primarily affects those in impoverished communities. Diagnosis is clinical, and treatment involves the removal of the flea and management of symptoms. Prevention focuses on reducing exposure and improving living conditions.

If you suspect tungiasis, look for small, painful lesions on your feet, often with a black dot in the center. These are caused by a flea that burrows into the skin. Treatment involves removing the flea and keeping the area clean to prevent infection. Wearing shoes and maintaining good hygiene can help prevent future infestations.